Ipamorelin is a five-residue GHRP mimetic (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts on the ghrelin receptor
The rationale is that sermorelin ipamorelin engage complementary, non-competing receptor systems, producing a broader and more sustained stimulation of growth hormone release without redundant receptor saturation
doi: 10.1016/j.bbi.2022.06.016 46 QinLWuXBlockMLLiuYBreeseGRHongJ-Set al
Latest Clinical Progress (as of early 2026) Phase 1 Clinical Data: Preliminary results presented at the 2025 American Heart Association (AHA) Annual Meeting showed that after a single dose, patients experienced a maximum reduction in serum AGT levels of over 95%
GLP-1 drugs can be a helpful tool, but theyre not magic
Henry Sobo, MD Medical Weight Loss, Functional & Hormone Therapy, Connecticut GLP 3 and Retatrutide: The New Triple Receptor Weight Loss Drug Everyone Is Talking About Health headlines and social media have started using a new term in the weightloss world: GLP3. Some people online even claim they are already using GLP3 shots for faster results than Ozempic